ADVERTISEMENT

404

Not Found

Is this what you were looking for?

tag cancer flow cytometry biomarkers cell culture

The Scientist Staff | Mar 28, 2024
Flow Cytometry for the Masses
Richard P. Grant | Dec 1, 2011 | 2 min read
Tagging antibodies with rare earth metals instead of fluorescent molecules turns a veteran technique into a high-throughput powerhouse.
Flow Cytometry
Josh Roberts | May 4, 2003 | 8 min read
Courtesy of DakoCytomation Conventional wisdom holds that flow cytometers are expensive, massive, high-maintenance instruments that require trained operators. They are plumbed into centralized facilities of large institutions, where investigators can pay to have their cells sorted, or perform the analyses themselves (provided they have the requisite skills) under the watchful eye of the center's personnel. But as so often happens, the conventional wisdom is wrong. Nowadays, flow cytometers ar
Flow Cytometry On-a-Chip
Jeffrey M. Perkel | Jun 1, 2015 | 7 min read
Novel microfluidic devices give researchers new ways to count and sort single cells.
Bugs as Drugs to Boost Cancer Therapy
Danielle Gerhard, PhD | Jan 18, 2024 | 7 min read
Bioengineered bacteria sneak past solid tumor defenses to guide CAR T cells’ attacks.
Yeast Made to Harvest Light Hint at Evolution’s Past
Kamal Nahas, PhD | Feb 21, 2024 | 6 min read
Scientists transferred light-harvesting proteins into yeast for the first time, shining a light on the past lives of eukaryotic cells.
Free Flow
Jeffrey M. Perkel | Dec 1, 2015 | 7 min read
A sampling of free software for flow cytometry data analysis
Microfluidics: Biology’s Liquid Revolution
Laura Tran, PhD | Feb 26, 2024 | 8 min read
Microfluidic systems redefined biology by providing platforms that handle small fluid volumes, catalyzing advancements in cellular and molecular studies.
A blood sample containing white and red blood cells.
Enhancing Cell Morphology-Based Analysis
The Scientist and Deepcell | Aug 3, 2023 | 3 min read
Learn how the latest AI-driven technology uses morphology to comprehensively analyze and sort cell populations.
TAg
Jeffrey Perkel | Apr 29, 2001 | 2 min read
Antigen-specific T lymphocytes must be quantified in order to gauge the quality of an immune response. Typically this is accomplished using cytotoxicity assays or limiting dilution analysis (LDA), but these techniques are lengthy and provide indirect quantitation. Also, LDA cannot count nonproliferative cells. In 1996, Stanford University's Mark Davis developed an alternative strategy that overcomes these problems.1 Davis generated phycoerythrin-conjugated tetramers of human lymphocyte antigen (

Run a Search

ADVERTISEMENT